Topical Glycolysis Inhibition Restores MAVS-Associated Antiviral Signaling in Herpes Simplex Keratitis
Investigative Ophthalmology & Visual Science · 2026
DOI: 10.1167/iovs.67.8.63 ↗At a glance
Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Wei Xu and 8 co-authors. Institution: National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China. Major MEDLINE topics: Keratitis, Herpetic, Adaptor Proteins, Signal Transducing, Glycolysis. 29 references. The full text is freely available (open access, CC BY-NC-ND 4.0).
Abstract (original language)
Purpose
Herpes simplex keratitis (HSK) is a leading cause of infectious corneal blindness. Host antiviral responses, particularly type I interferon (IFN) signaling, are impaired during corneal herpes simplex virus type 1 (HSV-1) infection, partly due to viral immune evasion and metabolic reprogramming. This study investigated if topical glycolysis inhibition restores mitochondrial antiviral signaling (MAVS)-associated innate antiviral signaling and improves HSK outcomes.
Methods
In vitro and in vivo infection models were established using the HSV-1 McKrae strain. A stable hexokinase 2 (HK2)-knockdown human corneal epithelial cell (HCEC) line was generated using lentivirus. Protein/mRNA levels were analyzed via western blot (WB), immunofluorescence (IF), enzyme linked immunosorbent assay (ELISA) and real-time polymerase chain reaction (RT-PCR). Protein interactions were confirmed by co-immunoprecipitation (Co-IP). Murine corneal pathology and viral proteins were assessed by slit-lamp imaging, IF, and WB.
Results
Elevated HK2 expression was detected in HSK models. HK2 knockdown or 2-deoxy-d-glucose (2-DG)-mediated inhibition reduced HSV-1 replication (lower infected cell protein 0 [ICP0], higher interferon-stimulated gene 56 [ISG56]). Co-IP confirmed the interaction between HK2 and MAVS protein, and HK2 inhibition activated the TANK-binding kinase 1 (TBK1)/interferon regulatory factor 3 (IRF3) pathway. Topical application of 2-DG improved murine corneal epithelial integrity, reduced viral proteins (glycoprotein D, ICP0), and showed efficacy comparable to acyclovir.
Conclusions
Topical glycolysis inhibition enhances corneal antiviral defenses via MAVS-mediated type I IFN signaling, controlling HSV-1 and alleviating disease. It reveals a novel corneal metabolism-antiviral immunity link, highlights HK2 as a therapeutic target for HSK, and supports metabolic therapies for HSK and ocular herpes virus infections.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- National Clinical Research Center for Ocular Diseases, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
- State Key Laboratory of Eye Health, Eye Hospital, Wenzhou Medical University, Wenzhou, China.
- Department of Ophthalmology, West China Second University Hospital, Sichuan University, Chengdu, China.
- School of Biomedical Engineering, Hainan University, Sanya, China.
Cite
APA
Xu, W., Liu, H., Cheng, Z., Li, Q., Wu, X., He, Z., Xiao, D., Jiang, D., & Chen, W. (2026). Topical Glycolysis Inhibition Restores MAVS-Associated Antiviral Signaling in Herpes Simplex Keratitis. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.8.63
Vancouver
Xu W, Liu H, Cheng Z, Li Q, Wu X, He Z, et al. Topical Glycolysis Inhibition Restores MAVS-Associated Antiviral Signaling in Herpes Simplex Keratitis. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.8.63
BibTeX
@article{Xu2026,
author = {Xu, Wei and Liu, Huiru and Cheng, Zihan and Li, Qixin and Wu, Xiaoqing and He, Zesheng and Xiao, Decheng and Jiang, Dan and Chen, Wei},
title = {Topical Glycolysis Inhibition Restores MAVS-Associated Antiviral Signaling in Herpes Simplex Keratitis},
journal = {Investigative Ophthalmology & Visual Science},
year = {2026},
doi = {10.1167/iovs.67.8.63}
}
EUVIMED